A phase III randomized trial comparing glucocorticoid monotherapyversusglucocorticoid and rituximab in patients with autoimmune haemolytic anaemia

Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies

(2012) W. Barcellini et al.   BLOOD

A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia

(2012) D. M. Arnold et al.   BLOOD

Evidence-based focused review of the treatment of idiopathic warm immune hemolytic anemia in adults

(2011) M. Crowther et al.   BLOOD

Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia

(2010) F. Zaja et al.   BLOOD

Rituximab in Autoimmune Hematologic Diseases: Not Just a Matter of B Cells

(2010) Roberto Stasi   SEMINARS IN HEMATOLOGY

Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study

(2009) D. Dierickx et al.   JOURNAL OF INTERNAL MEDICINE

Efficacy and safety of rituximab in adults' warm antibody autoimmune haemolytic anemia: Retrospective analysis of 27 cases

(2008) Guillaume Bussone et al.   AMERICAN JOURNAL OF HEMATOLOGY

Rituximab in the treatment of autoimmune haematological disorders

(2008) Bernadette Garvey   BRITISH JOURNAL OF HAEMATOLOGY

Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura

(2008) F. Zaja et al.   HAEMATOLOGICA

Safety, efficacy, and immune reconstitution after rituximab therapy in pediatric patients with chronic or refractory hematologic autoimmune cytopenias

(2007) Aarati Rao et al.   PEDIATRIC BLOOD & CANCER